HIGHLIGHTS
- who: CASTLE and colleagues from the From April , to May, patients with CASTLE treated by postoperative or radical IMRT in our center were retrospectively reviewedWe collected clinicopathological data, treatment procedures, and clinical outcomes. The patterns of treatment failure were also analyzed. The study was approved by the Institutional Review Board of Fudan University Shanghai Cancer Center. Informed consent was obtained from all patients. Intensity-modulate radiotherapy have published the research: of carcinoma showing thymus-like differentiation treated with intensity-modulated radiotherapy, in the Journal: (JOURNAL)
- what: The authors reviewed the 11 years of clinical experience . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.